Herpes Zoster Ophthalmicus After COVID-19 Vaccination: Chance Occurrence or More?
Cornea
; 41(2): 254-256, 2022 Feb 01.
Article
in English
| MEDLINE | ID: covidwho-1636854
ABSTRACT
ABSTRACT As the understanding of COVID-19 infection becomes better, it is being recognized as a complex multisystem pathology rather than just affecting the lungs. Several ocular findings have been documented by researchers in individuals infected with COVID-19, and ocular symptoms may even be the first presenting feature of COVID-19 infection in 2.26% individuals. Several countries have started vaccination with inactivated or live vaccines to combat this pandemic, and varied side effects have been reported after vaccination. Few cases of herpes zoster have previously been reported in elderly patients with comorbidities after receiving COVID-19 vaccines. In this article, the authors described 2 interesting cases of herpes zoster ophthalmicus (HZO) after receiving a live COVID-19 vaccine. The first case was a 35-year-old immunocompetent man who developed HZO 3 days postvaccine. The second case was a 40-year-old immunocompetent man who developed HZO 28 days postvaccine. To the best of our knowledge, no literature to date has described HZO after live vaccine.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Conjunctivitis, Viral
/
Herpes Zoster Ophthalmicus
/
Vaccination
/
COVID-19
/
ChAdOx1 nCoV-19
Type of study:
Case report
/
Diagnostic study
/
Observational study
Topics:
Vaccines
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Cornea
Year:
2022
Document Type:
Article
Affiliation country:
ICO.0000000000002881
Similar
MEDLINE
...
LILACS
LIS